Impel NeuroPharma Announces Commercial Milestones and First-in-Human Use of Pressurized Olfactory Delivery (POD) Technology
SEATTLE--(BUSINESS WIRE)--Impel NeuroPharma, a medical device company developing a novel drug delivery device that enables drugs to bypass the blood-brain barrier (BBB) using direct nose-to-brain delivery, today announced a set of important milestones in its drive to commercialize its POD technology.